These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3165144)
1. [Aclarubicin-related pancreatitis in a child with AML]. Adachi S; Akiyama Y; Takimoto T; Tanizawa A; Kiriyama Y; Kubota Y; Mikawa H Rinsho Ketsueki; 1988 Mar; 29(3):385-8. PubMed ID: 3165144 [No Abstract] [Full Text] [Related]
2. [Treatment of acute myelogenous leukemia with concurrent administration of N4-behenoyl-ara-C, aclacinomycin A, 6-mercaptopurine and prednisolone]. Ino T; Saito M; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Okamoto M; Takada T; Imura H Rinsho Ketsueki; 1985 Feb; 26(2):139-46. PubMed ID: 3860668 [No Abstract] [Full Text] [Related]
3. [Acute pancreatitis during the treatment of BH-AC AMP regimen for acute non-lymphocytic leukemia]. Onozawa Y; Yahara Y; Imai Y; Kawaguchi K; Higashidani M; Yoshida M Rinsho Ketsueki; 1984 Nov; 25(11):1766-71. PubMed ID: 6543456 [No Abstract] [Full Text] [Related]
4. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy]. Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889 [No Abstract] [Full Text] [Related]
5. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy]. Takeyama H; Kataoka T; Yano K; Fukutani H; Watanabe E Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186 [No Abstract] [Full Text] [Related]
6. [Treatment of refractory acute lymphocytic leukemia in childhood with BH-AC, ACM, 6-MP, and prednisolone]. Karube T; Maehara M; Ijima H; Muchi H Rinsho Ketsueki; 1984 May; 25(5):613-8. PubMed ID: 6590894 [No Abstract] [Full Text] [Related]
7. Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy. Kyo T; Dohy H Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1641-52. PubMed ID: 3247827 [No Abstract] [Full Text] [Related]
8. [Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)]. Hirano M; Morishita Y; Ino T; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Saito M Rinsho Ketsueki; 1981 Mar; 22(3):299-305. PubMed ID: 6944508 [No Abstract] [Full Text] [Related]
9. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia]. Ishige K; Takagi T; Oguro M Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925 [TBL] [Abstract][Full Text] [Related]
10. Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias. Mitrou PS Eur J Haematol Suppl; 1987; 47():59-66. PubMed ID: 3471526 [No Abstract] [Full Text] [Related]
11. Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia. Fink FM; Grümayer ER; Kardos G; Revesz T; Gadner H; Schuler D Haematol Blood Transfus; 1987; 30():393-8. PubMed ID: 3305209 [No Abstract] [Full Text] [Related]
13. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia. Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434 [TBL] [Abstract][Full Text] [Related]
14. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A]. Beck JD Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845 [TBL] [Abstract][Full Text] [Related]
15. [Retrospective analysis of elderly patients > or = 60 years of age with acute leukemia]. Tabata M; Yoshida M; Izumi T; Kawano C; Kuribara R; Toshima M; Omine K; Takatoku M; Uchida M; Kirito K; Miyazato A; Takahashi H; Hoshino M; Terui Y; Tomizuka H; Otsuki T; Shimizu R; Tsunoda J; Muroi K; Furukawa Y; Amemiya Y; Imagawa S; Komatsu N; Suzuki T; Miura Y Rinsho Ketsueki; 1998 Mar; 39(3):176-84. PubMed ID: 9577640 [TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia in adults: experience at AIIMS. Raina V; Kochupillai V J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155 [No Abstract] [Full Text] [Related]
17. Results of aggressive chemotherapy for myelodysplastic syndromes. Dohy H; Kyo T Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1428-34. PubMed ID: 3247817 [No Abstract] [Full Text] [Related]
18. [Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)]. Shimazaki C; Nakajima Y; Ura Y; Hamami T; Haruyama H; Isemura T; Nakagawa M; Ijichi H Rinsho Ketsueki; 1981 Jul; 22(7):1116-22. PubMed ID: 6948970 [No Abstract] [Full Text] [Related]
19. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside]. Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900 [No Abstract] [Full Text] [Related]
20. [New agents in the treatment of leukemia and lymphoma]. Yamada K Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079 [No Abstract] [Full Text] [Related] [Next] [New Search]